Anti-STAT1 Purified

*Kovarik J, Boudny V, Kocak I, Lauerova L, Fait V, Vagundova M: Malignant melanoma associates with deficient IFN-induced STAT 1 phosphorylation. Int J Mol Med. 2003 Sep;12 (3) :335-40. , URL: https://www.ncbi.nlm.nih.gov/pubmed/12883649?dopt=, *Boudny V, Kocak I, Lauerova L, Kovarik J: Interferon inducibility of STAT 1 activation and its prognostic significance in melanoma patients. Folia Biol (Praha) . 2003;49 (4) :142-6., URL: https://www.ncbi.nlm.nih.gov/pubmed/12971583?dopt=

*Kovarik P, Stoiber D, Eyers PA, Menghini R, Neininger A, Gaestel M, Cohen P, Decker T: Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen-activated protein kinase whereas IFN-gamma uses a different signaling pathway. Proc Natl Acad Sci U S A. 1999 Nov 23;96 (24) :13956-61., URL: https://www.ncbi.nlm.nih.gov/pubmed/10570180?ordin, *Frank DA: STAT signaling in the pathogenesis and treatment of cancer. Mol Med. 1999 Jul;5 (7) :432-56., URL: https://www.ncbi.nlm.nih.gov/pubmed/10449805?ordin, *Bromberg J, Darnell JE Jr: The role of STATs in transcriptional control and their impact on cellular function. Oncogene. 2000 May 15;19 (21) :2468-73., URL: https://www.ncbi.nlm.nih.gov/pubmed/10851045?ordin, *Soond SM, Townsend PA, Barry SP, Knight RA, Latchman DS, Stephanou A: ERK and the E3 ubiquitin ligase beta TRCP targets STAT1 for degradation. J Biol Chem. 2008 Mar 31, URL: https://www.ncbi.nlm.nih.gov/pubmed/18378670?ordin